NCT01202890
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer No drug interventions treatment 1 terminated NCT05261490
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer No drug interventions treatment 1 / 2 terminated NCT05622890
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer No drug interventions treatment 3 recruiting NCT03213964
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int No drug interventions treatment 1 completed NCT03740464
Long-acting G-CSF for Febrile Neutropenia No drug interventions treatment 3 unknown_status NCT02595021
Total/Subtotal Colectomy in Ovarian Cancer No drug interventions treatment 2 unknown_status NCT02952521
Ovarian Tumor Biopsies to Study Response to Treatments No drug interventions Not Available Not Available completed NCT04537702
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients No drug interventions supportive_care Not Available completed NCT04515602
Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) No drug interventions treatment 3 not_yet_recruiting NCT04925284
Study of XB002 in Subjects With Solid Tumors (JEWEL-101) No drug interventions treatment 1 active_not_recruiting NCT05212779
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease No drug interventions Not Available Not Available active_not_recruiting NCT06386887
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer No drug interventions supportive_care Not Available recruiting NCT03106987
A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer. treatment 3 completed NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors treatment 1 completed NCT00889733
Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer treatment 1 / 2 terminated NCT04620954
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin treatment 1 / 2 unknown_status NCT01442051
Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available completed NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04516447
A Study of ZN-c3 in Patients With Ovarian Cancer treatment 1 recruiting NCT04562298
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer No drug interventions treatment 1 terminated NCT02606305
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 completed NCT06366997
Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test No drug interventions Not Available Not Available completed NCT02312661
Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer treatment 1 completed NCT00490711
Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer No drug interventions treatment 2 completed NCT05877911
Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy treatment 2 not_yet_recruiting NCT03371693
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT04986371
Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer Not Available Not Available not_yet_recruiting NCT05317078
A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications No drug interventions treatment 1 terminated NCT06341907
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC No drug interventions treatment 2 / 3 recruiting NCT01068509
Ovarian Cancer Vaccine for Patients in Remission treatment 2 completed NCT01851109
Prevention of Ovarian Cancer in Women Participating in Mammography No drug interventions prevention Not Available completed NCT04279509
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE) No drug interventions diagnostic Not Available unknown_status NCT01506856
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial treatment 2 / 3 completed NCT05874115
Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT01832415
First Line Ovarian Cancer Treatment - Cohort Study Not Available Not Available completed NCT06173037
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer No drug interventions treatment 2 recruiting NCT03692637
Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer treatment 0 unknown_status NCT05284552
Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer treatment 2 recruiting NCT05773859
NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer No drug interventions treatment 1 / 2 recruiting NCT02834975
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). treatment 2 terminated NCT06315270
To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04846842
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 unknown_status NCT06305299
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells treatment 1 recruiting NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT03100006
Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin treatment 1 / 2 terminated NCT02487849
HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma treatment 2 withdrawn NCT00563836
Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer treatment 2 completed NCT01091636
Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer No drug interventions treatment 2 / 3 completed NCT03933813
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients No drug interventions supportive_care 1 / 2 terminated NCT01630018
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial treatment 2 completed NCT00616941
Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT05855941
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) No drug interventions Not Available Not Available recruiting NCT02159716
CART-meso in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT01000896
Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel treatment 1 withdrawn NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT03373058
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery No drug interventions treatment 3 unknown_status NCT04665635
Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery No drug interventions treatment Not Available recruiting NCT05801263
ctDNA Methylation for Epithelial Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT00407563
Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer No drug interventions treatment 2 completed NCT01018563
An Open Label Extension Study of the Efficacy of MORAb-003 treatment 2 terminated NCT05236686
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer No drug interventions treatment Not Available not_yet_recruiting NCT04015739
Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse treatment 2 unknown_status NCT02324439
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission No drug interventions prevention 1 completed NCT04473339
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation No drug interventions treatment 3 unknown_status NCT02728830
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers treatment 0 completed NCT05489926
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure treatment 2 active_not_recruiting NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies treatment 1 recruiting NCT02480374
Study of Safety & Biological Activity of IP IMNN-001 (Also Known as GEN-1) With Neoadjuvant Chemo in Ovarian Cancer treatment 1 completed NCT00861120
Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type treatment 2 completed NCT04651920
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer No drug interventions Not Available Not Available completed NCT04864431
Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer No drug interventions treatment Not Available unknown_status NCT00989131
Study of Paclitaxel in Patients With Ovarian Cancer treatment 3 completed NCT04555473
Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids No drug interventions Not Available Not Available unknown_status NCT04063527
Phase III Trial of Stage I Ovarian Cancer After Surgery treatment 3 recruiting NCT03332576
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT00880360
A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer treatment 2 completed NCT06539091
Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer treatment 3 not_yet_recruiting NCT01617629
Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study treatment 2 completed NCT06087289
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions treatment 1 / 2 recruiting NCT01773889
A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer No drug interventions treatment 2 terminated NCT00421889
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment No drug interventions treatment 1 / 2 completed NCT02012192
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer No drug interventions treatment 1 / 2 terminated NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT02855944
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients No drug interventions treatment 3 completed NCT01666444
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer No drug interventions treatment 2 completed NCT01121640
A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women No drug interventions screening Not Available completed NCT00850772
Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer No drug interventions supportive_care 3 completed NCT05199272
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT02323568
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. No drug interventions diagnostic Not Available completed NCT01681368
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer No drug interventions treatment 2 terminated NCT04670068
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian No drug interventions treatment 1 recruiting NCT04027868
Genomic BRCA and Extensive ovArian Cancer Testing No drug interventions Not Available Not Available completed NCT03754569
Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer No drug interventions basic_science Not Available completed NCT04651946
Cell-free DNA Methylation for Epithelial Ovarian Cancer No drug interventions diagnostic 2 unknown_status NCT03522246
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy No drug interventions treatment 3 active_not_recruiting NCT05172310
PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI No drug interventions diagnostic 1 recruiting NCT04504110
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings No drug interventions diagnostic 2 unknown_status NCT05316181
HIPEC for Platinum-Resistant Recurrent Ovarian Cancer No drug interventions treatment 3 recruiting NCT04889495
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04209855
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression No drug interventions treatment 3 active_not_recruiting NCT03607955
Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy No drug interventions treatment 1 withdrawn NCT03093155
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab No drug interventions treatment 2 completed NCT02915523
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer No drug interventions treatment 1 / 2 completed NCT02859038
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) No drug interventions treatment 3 unknown_status NCT06068738
Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT01840943
A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy No drug interventions treatment 3 terminated NCT00408603
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer No drug interventions treatment 2 completed NCT00538603
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) No drug interventions treatment Not Available completed NCT01439490
FES-PET to Determine ER-expression in Epithelial Ovarian Cancer No drug interventions diagnostic 2 completed NCT04296890
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression No drug interventions treatment 3 completed NCT02124421
HOT: HIPEC in Ovarian Cancer as Initial Treatment No drug interventions treatment 2 active_not_recruiting NCT02477202
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation No drug interventions treatment Not Available completed NCT03393884
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) No drug interventions treatment 1 / 2 active_not_recruiting NCT04651933
A Training Set for the HRD Model in EOC No drug interventions Not Available Not Available unknown_status NCT05483933
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers No drug interventions treatment 1 active_not_recruiting NCT05403554
A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers No drug interventions treatment 1 recruiting NCT03155451
Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer. No drug interventions Not Available Not Available completed NCT03025477
Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer No drug interventions treatment 2 recruiting NCT03862677
Determining Prognostic Immune Markers in Patients With Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03180177
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT06277947
Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward No drug interventions treatment Not Available not_yet_recruiting NCT04421547
Efficacy of Letrozole in Recurrent Ovarian Cancer No drug interventions treatment 3 unknown_status NCT06378905
Cukurova Score Validation Study No drug interventions Not Available Not Available recruiting NCT05422183
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer No drug interventions treatment 2 unknown_status NCT05397093
ITIL-306 in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03954171
Platino-resistance in Ovarian Cancer No drug interventions other Not Available recruiting NCT00314678
Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer No drug interventions treatment 2 completed NCT03321188
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients No drug interventions treatment 2 recruiting NCT03742388
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors No drug interventions Not Available Not Available unknown_status NCT05856409
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence No drug interventions Not Available Not Available recruiting NCT03742856
A Multi-omics Study of Epithelial Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT06085456
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study No drug interventions Not Available Not Available recruiting NCT03622385
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT00281515
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer No drug interventions treatment 2 completed NCT00226915
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma No drug interventions treatment 3 completed NCT02681432
Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer No drug interventions treatment 3 unknown_status NCT04726332
Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) No drug interventions treatment 1 terminated NCT05991752
Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized Trial No drug interventions diagnostic Not Available not_yet_recruiting NCT02947152
HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma No drug interventions treatment 1 terminated NCT04191252
Genetic Mutation in Epithelial Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT05200559
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01680575
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT05984875
The Immune Landscape of Epithelial Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05429970
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) No drug interventions prevention Not Available recruiting NCT05310370
HRD and Resistance to PAPPi in EOC Patients No drug interventions Not Available Not Available recruiting NCT01238770
Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer No drug interventions treatment 1 / 2 completed NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06483399
Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients No drug interventions Not Available Not Available completed NCT00968799
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study No drug interventions treatment Not Available terminated NCT01447706
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers No drug interventions treatment 2 completed NCT00596349
Women Surviving Ovarian Cancer No drug interventions Not Available Not Available completed NCT01649336
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer No drug interventions treatment 1 completed NCT02668913
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer No drug interventions diagnostic Not Available completed NCT04493619
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer No drug interventions treatment 1 / 2 terminated NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT02943317
Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer No drug interventions treatment 1 terminated NCT02022917
Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer No drug interventions treatment 2 completed NCT05585034
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04676334
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib No drug interventions treatment 3 completed NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer No drug interventions treatment 1 / 2 recruiting NCT05215496
[18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer No drug interventions diagnostic 1 terminated NCT02489058
A Study of Long-Term Responders on Olaparib No drug interventions Not Available Not Available completed NCT06223763
SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery No drug interventions Not Available Not Available recruiting NCT01549925
Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand No drug interventions treatment Not Available completed NCT05870748
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 No drug interventions treatment 2 / 3 recruiting NCT05310357
Chromosomal Instability in Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01663857
A Study LY2228820 for Recurrent Ovarian Cancer No drug interventions treatment 1 / 2 completed NCT00428766
Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer No drug interventions treatment 1 completed NCT06086665
The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer No drug interventions Not Available Not Available completed NCT04716374
Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer No drug interventions Not Available Not Available completed NCT01276574
Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT No drug interventions Not Available Not Available active_not_recruiting NCT02376231
To Evaluate Plasmajet in Achieving Complete Cytoreduction of Advanced EOC- Initial Feasibility Study No drug interventions treatment Not Available completed NCT04546373
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer No drug interventions Not Available Not Available completed NCT04539327
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study No drug interventions Not Available Not Available completed NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors No drug interventions treatment 2 recruiting NCT03268876
The INFLUENCE of Cytoreduction on PRO in EOC No drug interventions Not Available Not Available recruiting NCT02631876
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer No drug interventions treatment 3 completed NCT05801276
ctDNA Methylation for Detecting Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT04101760
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer No drug interventions treatment 3 unknown_status NCT02900560
Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer No drug interventions treatment 2 terminated NCT04706962
TH1902 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01004380
Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer No drug interventions Not Available 1 completed NCT04644289
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC No drug interventions treatment 2 recruiting NCT02728492
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy No drug interventions treatment 1 completed NCT01891344
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) No drug interventions treatment 2 completed NCT00086567
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers No drug interventions Not Available Not Available completed NCT06010667
A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04190667
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer No drug interventions Not Available Not Available unknown_status NCT01095367
Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer No drug interventions treatment Not Available terminated NCT03824704
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) No drug interventions treatment 2 terminated NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors No drug interventions diagnostic 2 recruiting NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05385068
A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi No drug interventions treatment 2 unknown_status NCT02644369
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors No drug interventions treatment 2 active_not_recruiting NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors No drug interventions treatment 1 completed NCT06412510
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT No drug interventions supportive_care 1 / 2 recruiting NCT06469281
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers No drug interventions treatment 1 recruiting NCT01146795
Neoadjuvant Therapy for Ovarian Cancer No drug interventions treatment 2 completed NCT00561795
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors No drug interventions treatment 2 completed NCT01164995
Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer No drug interventions treatment 2 completed NCT04983550
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC No drug interventions treatment 2 unknown_status NCT04001023
Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia No drug interventions treatment Not Available recruiting NCT05187208
PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer No drug interventions treatment 4 not_yet_recruiting NCT01521143
Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment No drug interventions treatment 2 terminated NCT00349505
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma No drug interventions treatment 2 unknown_status NCT02107378
Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma treatment 2 terminated NCT01138137
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer treatment 1 withdrawn NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT05086692
A Beta-only IL-2 ImmunoTherapY Study No drug interventions treatment 1 / 2 recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT02437812
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma No drug interventions treatment 2 unknown_status NCT02344095
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer No drug interventions treatment 1 completed NCT05470920
Genetic Testing Decision Aid No drug interventions health_services_research Not Available recruiting NCT04834544
A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care No drug interventions treatment 2 recruiting NCT01536743
A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression No drug interventions treatment 2 completed NCT05763199
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy No drug interventions prevention 2 recruiting NCT04794322
Developing a Test for the Detection of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05856643
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma No drug interventions treatment 0 recruiting NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT02062697
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. No drug interventions diagnostic Not Available completed NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT02742428
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer No drug interventions supportive_care Not Available suspended NCT04823871
Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing No drug interventions diagnostic Not Available completed NCT04029909
A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer treatment 1 unknown_status NCT01484015
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia treatment 1 completed NCT03220932
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer treatment 3 unknown_status NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT02489903
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) No drug interventions treatment 2 completed NCT02096783
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer No drug interventions supportive_care Not Available completed NCT06404671
Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT02039388
Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma No drug interventions diagnostic Not Available completed NCT02518256
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity No drug interventions prevention Not Available completed NCT02107937
Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma No drug interventions treatment 2 completed NCT03078400
Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer No drug interventions treatment 1 unknown_status NCT03349463
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. No drug interventions diagnostic 4 unknown_status NCT02435186
p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer No drug interventions treatment 2 unknown_status NCT02822157
Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer No drug interventions treatment 2 unknown_status NCT01456065
Safety of Active Immunotherapy in Subjects With Ovarian Cancer No drug interventions treatment 1 unknown_status NCT05937620
Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer No drug interventions diagnostic Not Available not_yet_recruiting NCT02981901
Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France No drug interventions Not Available Not Available unknown_status NCT02107950
Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma No drug interventions treatment 2 completed NCT01806350
Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors No drug interventions supportive_care Not Available completed NCT04885270
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer treatment 3 unknown_status NCT02135523
The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial No drug interventions treatment Not Available completed NCT04519151
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer treatment 2 recruiting NCT04556071
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT03976999
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers No drug interventions other Not Available recruiting NCT04196257
BP1001-A in Patients With Advanced or Recurrent Solid Tumors treatment 1 recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT06121401
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients No drug interventions other 4 recruiting NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer No drug interventions treatment 1 recruiting NCT04566952
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer No drug interventions treatment 2 unknown_status NCT05601700
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) No drug interventions treatment 3 recruiting NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery No drug interventions treatment 3 active_not_recruiting NCT04807166
Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer No drug interventions treatment 2 active_not_recruiting NCT05158062
Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer No drug interventions treatment 2 recruiting NCT05544929
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers No drug interventions treatment 1 recruiting NCT05116189
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65) No drug interventions treatment 3 active_not_recruiting NCT01080521
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy No drug interventions Not Available Not Available completed NCT00748657
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary treatment 2 completed NCT02020707
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers No drug interventions treatment 1 completed NCT00897442
Collecting Tumor Samples From Patients With Gynecological Tumors No drug interventions Not Available Not Available completed NCT04055649
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer No drug interventions treatment 2 recruiting